About Where Tech Meets Bio
A weekly intelligence newsletter covering AI drug discovery, pharma R&D transformation, and the companies driving change in biotech. Published by WTMB Group (WTMB Research & Media, S.L.), read by 11,500+ professionals from leading pharmaceutical and biotech companies, biotech startups, venture capital funds, and government organizations.
Each week, we publish two editions: a curated news highlights roundup covering the most significant deals, partnerships, and breakthroughs in the pharmaceutical and biotech industries. We focus on things that impact business, markets and industry direction.
Where Tech Meets Bio Writers
👤 Andrii Buvailo, PhD — Co-founder and Director of WTMB Group (WTMB Research & Media, S.L.), a company that operates BiopharmaTrend, the Where Tech Meets Bio newsletter, and The Biotech Edge newsletter on LinkedIn. Andrii is a biotech and AI analyst whose work has been cited by Deloitte, RAND Corporation, US Department of Energy, European Parliament, and in peer-reviewed scientific research.
👤 Roman Kasianov — Contributing editor and analyst at WTMB Group and BiopharmaTrend. A seasoned science writer who helped shape the editorial direction of the Where Tech Meets Bio and grow it into a leading biotech-focused newsletter on Substack.
Free vs. Paid
Weekly highlights and select deep dives are free. The full analytical deep dive archive, including company picks, trend analysis, and landscape mapping, is available to paid subscribers.
Some of the recent deep dives:
For corporate readers: Many of our subscribers expense this newsletter as a professional development or market intelligence resource. Substack automatically provides receipts for all paid subscriptions that can be submitted to your organization's expense system. If you need additional documents to expense this newsletter with your organization, reach out to info@biopharmatrend.com.
Sponsorship
To reach our audience of pharma, biotech, and healthtech decision-makers, request our media kit or contact info@wtmbgroup.com.
